SYMPHORNA Trademark
Trademark Overview
On Monday, September 8, 2025, a trademark application was filed for SYMPHORNA with the United States Patent and Trademark Office. The USPTO has given the SYMPHORNA trademark a serial number of 99379848. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, February 4, 2026. This trademark is owned by Uncommon Bio Limited. The SYMPHORNA trademark is filed in the Chemical Products, Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Medical Instrument Products, Advertising, Business and Retail Services, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:
Scientific and technological research in the fields of pharmaceuticals, biotechnology, and healthcare; pharmaceutical and biopharmaceutical research and development; development of mRNA-based therapeutics and vaccines; genetic and molecular biology research; laboratory services; laboratory testing and analysis; bioinformatics and computational biology; AI-based drug discovery services; genetic profiling for therapeutic purposes; design and testing of drug delivery systems and personalised medicine platforms; industrial research and quality control services; technological consultancy in complex scientific fields; consultancy relating to biotechnology and pharmaceutical development; research and development of dietary supplements and nutraceuticals; software as a service (SaaS) and platform services for the design, modelling, or optimisation of RNA sequences, delivery technologies, and therapeutic formulations
Chemical substances and organic compounds for the manufacture of pharmaceuticals and dietary supplements and for use in the biotechnology industry; preservatives for use in the pharmaceutical and food industries; nucleic acids, RNA, and mRNA for laboratory use; plasmids and gene vectors for research purposes; lipids and lipid-based substances for use in drug delivery systems; biologically active molecules for use in biotechnology; biochemical catalysts; culture media and reagents for growing cells and tissues in laboratory conditions; plant extracts for industrial and research use; vitamins, minerals, and proteins for use in food and supplement manufacture; Lipids and lipid-based formulations for industrial use in pharmaceutical and biotechnological manufacturing; fatty substances and carrier compounds for use in the production of therapeutic and nutritional products; lipid nanoparticles and other excipients for industrial use in drug delivery and supplement formulation
Custom manufacture of pharmaceuticals, biopharmaceuticals, gene therapy products, dietary supplements, and therapeutic delivery systems; manufacturing of personalised medicine products; processing and synthesis of nucleic acids, including mRNA and DNA; production and purification of biological substances and reagents; formulation of lipid and polymer-based drug delivery systems; chemical or biological processing or transformation of organic substances, lipids, polymers, and excipients at the request of third parties; contract manufacturing of therapeutics, supplements, and RNA delivery platforms; production of synthetic genes, oligonucleotides, chemically modified RNAs, polymer conjugates, and lipid–polymer complexes
Retail and wholesale services in connection with pharmaceuticals, biopharmaceuticals, dietary and nutritional supplements, medical devices, chemical substances and organic compounds for biotechnology and pharmaceutical use, laboratory reagents, diagnostic test kits, lipids and lipid-based formulations, plant-based supplements, vitamins, minerals, and other nutraceuticals; online retail services in the field of biotechnology, diagnostics, and healthcare products; retail services relating to RNA-based therapeutics, delivery systems, and oligonucleotide products
biological and pharmaceutical preparations for medical and veterinary use; sanitary preparations for medical use; RNA-based vaccines and therapeutics; oligonucleotide-based therapeutics; gene therapy preparations; CRISPR-based therapeutics and genome editing agents; immunotherapeutic agents; therapeutic preparations for modulation of immune responses; personalised medicine formulations; cell-based pharmaceutical preparations; in vivo cell therapy preparations in the form of pharmaceutical compositions; ex vivo cell therapy preparations in the form of pharmaceutical compositions comprising modified or unmodified cells for administration to patients; regenerative and tissue-based therapeutic products; pharmaceutical preparations incorporating lipid nanoparticles or other delivery systems; diagnostic reagents and test kits for medical use; veterinary preparations; dietetic food and substances adapted for medical or veterinary use; dietary supplements; nutritional supplements
Medical and diagnostic apparatus and instruments; injectors and drug delivery devices; wearable and implantable medical devices for administering pharmaceutical or gene therapy preparations; microneedle patches; transfection devices; medical diagnostic test kits for clinical and laboratory use; apparatus for RNA-based therapeutic delivery; devices for personalised medicine and genetic diagnostics; medical apparatus incorporating biosensors, nucleic acid detection systems, or AI-based diagnostic components; devices for nucleic acid transfection and RNA delivery
Downloadable software and mobile applications for use in the design, analysis, modelling, or optimisation of nucleic acid sequences, including RNA-based therapeutics; software for use in therapeutic delivery system design; software for bioinformatics, genetic analysis, and molecular diagnostics; downloadable databases and data management tools for drug discovery and personalised medicine; Downloadable machine learning software for identifying and predicting therapeutic targets, molecular interactions, or genetic biomarkers; downloadable artificial intelligence software for bioinformatics, genetic analysis, and drug discovery; software for use in pharmaceutical research, formulation design, and RNA delivery platform development
General Information
| Serial Number | 99379848 |
| Word Mark | SYMPHORNA |
| Filing Date | Monday, September 8, 2025 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Wednesday, February 4, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Goods and Services | Scientific and technological research in the fields of pharmaceuticals, biotechnology, and healthcare; pharmaceutical and biopharmaceutical research and development; development of mRNA-based therapeutics and vaccines; genetic and molecular biology research; laboratory services; laboratory testing and analysis; bioinformatics and computational biology; AI-based drug discovery services; genetic profiling for therapeutic purposes; design and testing of drug delivery systems and personalised medicine platforms; industrial research and quality control services; technological consultancy in complex scientific fields; consultancy relating to biotechnology and pharmaceutical development; research and development of dietary supplements and nutraceuticals; software as a service (SaaS) and platform services for the design, modelling, or optimisation of RNA sequences, delivery technologies, and therapeutic formulations |
| Description of Mark | The mark consists of SYMPHORNA in stylized font. |
| Goods and Services | Chemical substances and organic compounds for the manufacture of pharmaceuticals and dietary supplements and for use in the biotechnology industry; preservatives for use in the pharmaceutical and food industries; nucleic acids, RNA, and mRNA for laboratory use; plasmids and gene vectors for research purposes; lipids and lipid-based substances for use in drug delivery systems; biologically active molecules for use in biotechnology; biochemical catalysts; culture media and reagents for growing cells and tissues in laboratory conditions; plant extracts for industrial and research use; vitamins, minerals, and proteins for use in food and supplement manufacture; Lipids and lipid-based formulations for industrial use in pharmaceutical and biotechnological manufacturing; fatty substances and carrier compounds for use in the production of therapeutic and nutritional products; lipid nanoparticles and other excipients for industrial use in drug delivery and supplement formulation |
| Goods and Services | Custom manufacture of pharmaceuticals, biopharmaceuticals, gene therapy products, dietary supplements, and therapeutic delivery systems; manufacturing of personalised medicine products; processing and synthesis of nucleic acids, including mRNA and DNA; production and purification of biological substances and reagents; formulation of lipid and polymer-based drug delivery systems; chemical or biological processing or transformation of organic substances, lipids, polymers, and excipients at the request of third parties; contract manufacturing of therapeutics, supplements, and RNA delivery platforms; production of synthetic genes, oligonucleotides, chemically modified RNAs, polymer conjugates, and lipid–polymer complexes |
| Goods and Services | Retail and wholesale services in connection with pharmaceuticals, biopharmaceuticals, dietary and nutritional supplements, medical devices, chemical substances and organic compounds for biotechnology and pharmaceutical use, laboratory reagents, diagnostic test kits, lipids and lipid-based formulations, plant-based supplements, vitamins, minerals, and other nutraceuticals; online retail services in the field of biotechnology, diagnostics, and healthcare products; retail services relating to RNA-based therapeutics, delivery systems, and oligonucleotide products |
| Goods and Services | biological and pharmaceutical preparations for medical and veterinary use; sanitary preparations for medical use; RNA-based vaccines and therapeutics; oligonucleotide-based therapeutics; gene therapy preparations; CRISPR-based therapeutics and genome editing agents; immunotherapeutic agents; therapeutic preparations for modulation of immune responses; personalised medicine formulations; cell-based pharmaceutical preparations; in vivo cell therapy preparations in the form of pharmaceutical compositions; ex vivo cell therapy preparations in the form of pharmaceutical compositions comprising modified or unmodified cells for administration to patients; regenerative and tissue-based therapeutic products; pharmaceutical preparations incorporating lipid nanoparticles or other delivery systems; diagnostic reagents and test kits for medical use; veterinary preparations; dietetic food and substances adapted for medical or veterinary use; dietary supplements; nutritional supplements |
| Goods and Services | Medical and diagnostic apparatus and instruments; injectors and drug delivery devices; wearable and implantable medical devices for administering pharmaceutical or gene therapy preparations; microneedle patches; transfection devices; medical diagnostic test kits for clinical and laboratory use; apparatus for RNA-based therapeutic delivery; devices for personalised medicine and genetic diagnostics; medical apparatus incorporating biosensors, nucleic acid detection systems, or AI-based diagnostic components; devices for nucleic acid transfection and RNA delivery |
| Goods and Services | Downloadable software and mobile applications for use in the design, analysis, modelling, or optimisation of nucleic acid sequences, including RNA-based therapeutics; software for use in therapeutic delivery system design; software for bioinformatics, genetic analysis, and molecular diagnostics; downloadable databases and data management tools for drug discovery and personalised medicine; Downloadable machine learning software for identifying and predicting therapeutic targets, molecular interactions, or genetic biomarkers; downloadable artificial intelligence software for bioinformatics, genetic analysis, and drug discovery; software for use in pharmaceutical research, formulation design, and RNA delivery platform development |
Classification Information
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 8, 2025 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 8, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus. |
| US Class Codes | 021, 023, 026, 036, 038 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 8, 2025 |
| Primary Code | 009 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 8, 2025 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 8, 2025 |
| Primary Code | 035 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 8, 2025 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, September 8, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Uncommon Bio Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Cambridge CB5 8PB
GB |
Trademark Events
| Event Date | Event Description |
| Monday, September 8, 2025 | NEW APPLICATION ENTERED |
| Monday, September 8, 2025 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, January 27, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, January 28, 2026 | ASSIGNED TO EXAMINER |
| Wednesday, February 4, 2026 | NON-FINAL ACTION WRITTEN |
| Wednesday, February 4, 2026 | NON-FINAL ACTION E-MAILED |
| Wednesday, February 4, 2026 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, April 29, 2026 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Wednesday, April 29, 2026 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
